This can be easily understood from the fact that desmosterol activates LXRα in macrophages/KCs only, whereas LXR‐induced hyperlipidemia is mainly due to increased de novo lipogenesis within hepatocytes (Muse et al, 2018). Here, NR1H3 is linked to hyperlipidemia.